Nucleic Acid Extraction Instruments and Reagents Market Report 2025

The nucleic acid extraction instruments and reagents market size has grown strongly in recent years. It will grow from $4.56 billion in 2024 to $5.01 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to genomic research advancements, clinical diagnostics expansion, the emergence of next-generation sequencing, increasing prevalence of genetic disorders, and global focus on infectious disease research.

The nucleic acid extraction instruments and reagents market size is expected to see rapid growth in the next few years. It will grow to $7.84 billion in 2029 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to rapid growth in personalized medicine, point-of-care testing expansion, increased focus on rare diseases, and advancements in cancer research. Major trends in the forecast period include applications in agricultural biotechnology, technological innovations in automation, biotechnology boom, environmental DNA (EDNA) analysis, and blockchain in genomic data security.

The rising prevalence of chronic diseases is anticipated to drive the growth of the nucleic acid extraction instruments and reagents market in the future. Chronic diseases are long-lasting medical conditions that persist over time and typically progress slowly. Nucleic acid extraction instruments and reagents are vital in the context of chronic diseases, especially in molecular diagnostics and research. These instruments and reagents are essential for studying, diagnosing, monitoring, and treating chronic diseases. They facilitate genetic testing, biomarker analysis, research, pharmacogenomic testing, and disease monitoring, all of which contribute to a better understanding and management of chronic conditions. For example, in September 2023, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported that 41 million deaths annually, accounting for 74% of deaths caused by non-communicable diseases (NCDs) or chronic diseases worldwide. Among these, there were 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2 million from diabetes. Thus, the growing prevalence of chronic diseases is propelling the growth of the nucleic acid extraction instruments and reagents market in the coming years.

The growing demand for personalized medicine is poised to fuel the expansion of the nucleic acid extraction instruments and reagents market. Personalized medicine, aimed at tailoring medical treatments based on individual characteristics, including genetic makeup, relies on specific nucleic acid extraction instruments and customized reagents. These tools enable the isolation and analysis of individual genetic material, facilitating the development of personalized treatment plans tailored to a patient's unique genetic profile. In 2022, the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% classified as personalized medicines by the Personalized Medicine Coalition (PMC). This emphasizes the increasing adoption of personalized medicine and its pivotal role in driving the growth of the nucleic acid extraction instruments and reagents market.

Major companies in the nucleic acid extraction instruments and reagents market are concentrating on developing innovative solutions, such as nucleic acid extraction systems, to highlight their commitment to innovation and address specific market demands. Nucleic acid extraction systems consist of a range of laboratory tools and technologies aimed at isolating and purifying nucleic acids (DNA and RNA) from biological samples like blood, tissues, cells, and other fluids. For example, in January 2024, LGC Biosearch Technologies, a biotechnology firm based in the UK, introduced the sbeadex Lightning nucleic acid extraction method. This method transforms DNA purification by allowing high-purity extraction from plant and animal samples in just five minutes. It streamlines the traditional five-step process into three steps - bind, wash, and elute - leading to a time reduction of up to 40 minutes per sample and a potential tenfold increase in throughput. The extracted DNA typically demonstrates high purity, with 260/280 ratios ranging from 1.7 to 2, making it suitable for applications like PCR and next-generation sequencing (NGS).

Major companies in the nucleic acid extraction instruments and reagents market are also focusing on creating innovative solutions, such as cell nucleic acid extraction kits, to enhance their product portfolios. A cell nucleic acid extraction kit is a specialized collection of reagents and tools designed to isolate nucleic acids (DNA and RNA) from different cell types, including those derived from tissues, blood, or cultures. For instance, in April 2023, Jiangsu Bioperfectus, a molecular diagnostics company based in China, launched two cutting-edge products: the SAW-48, an automated workstation that simplifies the nucleic acid extraction and PCR setup process for up to 48 samples simultaneously, and the Cell Nucleic Acid Extraction Kit, which utilizes a magnetic bead method for efficient extraction and purification of nucleic acids from various samples. These innovations aim to enhance laboratory diagnostics, particularly in infectious disease testing, and have received FDA and CE certification, validating their reliability and compliance with international health standards.

In January 2023, Qiagen N.V., a prominent biotechnology research company headquartered in Germany, completed the acquisition of Verogen Ltd for an estimated $150 million. This strategic acquisition by Qiagen grants exclusive distribution rights for a specialized MiSeq sequencer variant tailored specifically for forensics applications. Verogen Ltd, based in the Netherlands, specializes in the development of DNA-based biometric human identification products and nucleic acid extraction solutions.

Major companies operating in the nucleic acid extraction instruments and reagents market include Thermo Fisher Scientific Inc., F Hoffmann-La Roche Ltd., Merck Group, Corning Incorporated, Agilent Technologies Inc., PerkinElmer, Illumina Inc., Beckman Coulter, Bio-Rad Laboratories Inc., Qiagen NV, Eppendorf AG, LGC Biosearch Technologies, Promega Corporation, RBC Bioscience Corp., Takara Bio Inc., Meridian Bioscience, Bioneer Corporation, Macherey-Nagel, New England Biolabs, Miltenyi Biotec, Omega Bio-tek, BioVision Inc., Norgen Biotek Corp., Biosan Laboratories Inc., G-Biosciences, ADS Biotec Inc., BioChain Institute Inc., Lucigen Corporation.

North America was the largest region in the nucleic acid extraction instruments and reagents market in 2024. The regions covered in the nucleic acid extraction instruments and reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the nucleic acid extraction instruments and reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

Nucleic acid extraction instruments and reagents encompass the tools and substances instrumental in isolating and purifying nucleic acids such as DNA or RNA from biological samples. These components are pivotal in molecular biology, genetics, and diagnostic labs, aiding in vital research and analysis.

These essential tools and substances come in various types, including instruments, spin columns, beads (including magnetic ones), automated nucleic acid extraction systems, extraction kits and reagents, and consumables. Instruments are devices serving multiple functions, such as measurement, analysis, or experimentation. Extraction methods such as DNA, RNA, or DNA/RNA extraction rely on solution-based or solid-phase-based techniques. These products cater to diverse end users such as academic research institutes, hospitals, diagnostic centers, pharmaceutical and biotechnology industries, and contract research organizations (CROs).

The nucleic acid extraction instruments and reagents market research report is one of a series of new reports that provides nucleic acid extraction instruments and reagents market statistics, including nucleic acid extraction instruments and reagents industry global market size, regional shares, competitors with a nucleic acid extraction instruments and reagents market share, detailed nucleic acid extraction instruments and reagents market segments, market trends and opportunities, and any further data you may need to thrive in the nucleic acid extraction instruments and reagents industry. This nucleic acid extraction instruments and reagents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nucleic acid extraction instruments and reagents market consists of revenues earned by entities by providing nucleic acid extraction instruments and reagents services such as data management and analysis, and laboratory information management systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The nucleic acid extraction instruments and reagents market also includes sales of centrifuges, thermal cyclers, and robotic platforms, which are used in providing nucleic acid extraction instruments and reagents services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.